Evidence map›Paper›PMID 40401583›Full record

ArticleEmerging infectious diseases2025

Emergence of Oropouche Virus in Espírito Santo State, Brazil, 2024.

Edson Delatorre, Gabriela Colombo de Mendonça, Felipe Donateli Gatti, Anna Clara Gregório Có, Julia Del Piero Pereira, Eric Arrivabene Tavares, Joana Zorzal Nodari, Agata Rossi, Suwellen Sardinha Dias de Azevedo, Cláudio Tavares Sacchi and 8 more

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Edson Delatorre
Gabriela Colombo de Mendonça
Felipe Donateli Gatti
Anna Clara Gregório Có
Julia Del Piero Pereira
Eric Arrivabene Tavares
Joana Zorzal Nodari
Agata Rossi
Suwellen Sardinha Dias de Azevedo
Cláudio Tavares Sacchi
Karoline Rodrigues Campos
Adriana Bugno
Lyvia Neves Rebello Alves
Lucas André Silva Bonela
Jaqueline Pegoretti Goulart
Thiago de Jesus Sousa
Felipe Gomes Naveca
Rodrigo Ribeiro-Rodrigues

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oropouche virus (OROV), historically endemic to the Amazon, had spread to nearly all Brazil states by 2024; Espírito Santo emerged as a transmission hotspot in the Atlantic Forest biome. We characterized the epidemiologic factors driving OROV spread in nonendemic southeast Brazil, analyzing environmental and agricultural conditions contributing to viral transmission. We tested samples from 29,080 suspected arbovirus-infected patients quantitative reverse transcription PCR for OROV and dengue, chikungunya, Zika, and Mayaro viruses. During March‒June 2024, the state had 339 confirmed OROV cases, demonstrating successful local transmission. Spatial analysis revealed that most cases clustered in municipalities with tropical climates and intensive cacao, robusta coffee, coconut, and pepper cultivation. Phylogenetic analysis identified the Espírito Santo OROV strains as part of the 2022-2024 Amazon lineage. The rapid spread of OROV outside the Amazon highlights its adaptive potential and public health threat, emphasizing the need for enhanced surveillance and targeted control measures.

Indexed as

Bunyaviridae InfectionsCommunicable Diseases, EmergingOrthobunyavirusAdolescentAdultBrazilChildChild, PreschoolFemaleHumansMaleMiddle AgedPhylogenyYoung AdultarbovirusesBrazilclimatedisease outbreaksepidemiologyOropouche virussymptomsvector-borne infectionsviruses

Identifiers

PMID40401583
PMCPMC12123935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.